Literature DB >> 28986380

Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion.

Yongqiang Liu1, Larra W Yuelling1, Yuan Wang2, Fang Du1, Renata E Gordon1, Jenny A O'Brien1, Jessica M Y Ng3, Shannon Robins1, Eric H Lee1, Hailong Liu1, Tom Curran3, Zeng-Jie Yang4,2.   

Abstract

Astrocytes, the most abundant type of glial cells in the brain, play critical roles in supporting neuronal development and brain function. Although astrocytes have been frequently detected in brain tumors, including medulloblastoma (MB), their functions in tumorigenesis are not clear. Here, we demonstrate that astrocytes are essential components of the MB tumor microenvironment. Tumor-associated astrocytes (TAA) secrete the ligand sonic hedgehog (Shh), which is required for maintaining MB cell proliferation despite the absence of its primary receptor Patched-1 (Ptch1). Shh drives expression of Nestin in MB cells through a smoothened-dependent, but Gli1-independent mechanism. Ablation of TAA dramatically suppresses Nestin expression and blocks tumor growth. These findings demonstrate an indispensable role for astrocytes in MB tumorigenesis and reveal a novel Ptch1-independent Shh pathway involved in MB progression. Cancer Res; 77(23); 6692-703. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28986380      PMCID: PMC5759326          DOI: 10.1158/0008-5472.CAN-17-1463

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

2.  Essential protective roles of reactive astrocytes in traumatic brain injury.

Authors:  D J Myer; G G Gurkoff; S M Lee; D A Hovda; M V Sofroniew
Journal:  Brain       Date:  2006-07-05       Impact factor: 13.501

3.  Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

Authors:  Silvia Buonamici; Juliet Williams; Michael Morrissey; Anlai Wang; Ribo Guo; Anthony Vattay; Kathy Hsiao; Jing Yuan; John Green; Beatriz Ospina; Qunyan Yu; Lance Ostrom; Paul Fordjour; Dustin L Anderson; John E Monahan; Joseph F Kelleher; Stefan Peukert; Shifeng Pan; Xu Wu; Sauveur-Michel Maira; Carlos García-Echeverría; Kimberly J Briggs; D Neil Watkins; Yung-mae Yao; Christoph Lengauer; Markus Warmuth; William R Sellers; Marion Dorsch
Journal:  Sci Transl Med       Date:  2010-09-29       Impact factor: 17.956

4.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

5.  Patched2 modulates tumorigenesis in patched1 heterozygous mice.

Authors:  Youngsoo Lee; Heather L Miller; Helen R Russell; Kelli Boyd; Tom Curran; Peter J McKinnon
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

6.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

Authors:  K W Culver; Z Ram; S Wallbridge; H Ishii; E H Oldfield; R M Blaese
Journal:  Science       Date:  1992-06-12       Impact factor: 47.728

8.  Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure.

Authors:  Hiromichi Kimura; Jessica M Y Ng; Tom Curran
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

9.  The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins.

Authors:  Eric W Humke; Karolin V Dorn; Ljiljana Milenkovic; Matthew P Scott; Rajat Rohatgi
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

Review 10.  Reappraisal of Bergmann glial cells as modulators of cerebellar circuit function.

Authors:  Chris I De Zeeuw; Tycho M Hoogland
Journal:  Front Cell Neurosci       Date:  2015-07-02       Impact factor: 5.505

View more
  18 in total

1.  Astrocytes: new stars in the medulloblastoma firmament.

Authors:  Charles Eberhart
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

2.  Leukotriene Synthesis Is Critical for Medulloblastoma Progression.

Authors:  Fang Du; Larra Yuelling; Eric H Lee; Yuan Wang; Shengyou Liao; Yan Cheng; Li Zhang; Chaonan Zheng; Suraj Peri; Kathy Q Cai; Jessica M Y Ng; Tom Curran; Peng Li; Zeng-Jie Yang
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

3.  Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-α.

Authors:  Biao Gong; Duancheng Guo; Chaonan Zheng; Zhen Ma; Jie Zhang; Yanghui Qu; Xinhua Li; Gen Li; Li Zhang; Yuan Wang
Journal:  J Neuroinflammation       Date:  2022-06-20       Impact factor: 9.587

4.  Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion.

Authors:  Hailong Liu; Youliang Sun; Jenny A O'Brien; Janusz Franco-Barraza; Xueling Qi; Hongyu Yuan; Wei Jin; Junping Zhang; Chunyu Gu; Zhenyu Zhao; Chunjiang Yu; Shiyu Feng; Xinguang Yu
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

Review 5.  Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer.

Authors:  Tom Curran
Journal:  Open Biol       Date:  2018-08       Impact factor: 6.411

Review 6.  Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.

Authors:  Otília Menyhárt; Balázs Győrffy
Journal:  Ann Clin Transl Neurol       Date:  2019-03-19       Impact factor: 4.511

Review 7.  Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment.

Authors:  Lukas Tamayo-Orrego; Frédéric Charron
Journal:  F1000Res       Date:  2019-10-29

Review 8.  Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy.

Authors:  Zahraa F Audi; Zahraa Saker; Mahdi Rizk; Hisham F Bahmad; Sanaa M Nabha; Hayat Harati; Youssef Fares
Journal:  Curr Treat Options Oncol       Date:  2021-07-30

9.  Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.

Authors:  Duancheng Guo; Yuan Wang; Yan Cheng; Shengyou Liao; Jian Hu; Fang Du; Gang Xu; Yongqiang Liu; Kathy Q Cai; Martin Cheung; Brandon J Wainwright; Q Richard Lu; Yi Zhao; Zeng-Jie Yang
Journal:  J Exp Med       Date:  2021-07-13       Impact factor: 14.307

10.  Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan.

Authors:  Gaohai Shao; Qingjun Liu; Ling Yang; Guibo Feng; Wang Zhao; Zhongyan Huang; Zhao Yang
Journal:  J Inflamm (Lond)       Date:  2020-02-19       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.